A detailed history of Exchange Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Exchange Bank holds 989 shares of LLY stock, worth $759,314. This represents 0.72% of its overall portfolio holdings.

Number of Shares
989
Previous 1,122 11.85%
Holding current value
$759,314
Previous $1.02 Billion 13.75%
% of portfolio
0.72%
Previous 0.86%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$772.14 - $960.02 $102,694 - $127,682
-133 Reduced 11.85%
989 $876 Million
Q2 2024

Jul 10, 2024

SELL
$724.87 - $909.04 $29,719 - $37,270
-41 Reduced 3.53%
1,122 $1.02 Billion
Q1 2024

Apr 12, 2024

SELL
$592.2 - $792.28 $8,290 - $11,091
-14 Reduced 1.19%
1,163 $905 Million
Q4 2023

Jan 11, 2024

SELL
$525.19 - $619.13 $25,209 - $29,718
-48 Reduced 3.92%
1,177 $686 Million
Q3 2023

Nov 15, 2023

SELL
$434.7 - $599.3 $34,341 - $47,344
-79 Reduced 6.06%
1,225 $658 Million
Q2 2023

Nov 15, 2023

BUY
$350.74 - $468.98 $457,364 - $611,549
1,304 New
1,304 $612 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Exchange Bank Portfolio

Follow Exchange Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Bank, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Bank with notifications on news.